ARTICLE | Distillery Therapeutics
Cancer
September 20, 2017 6:57 PM UTC
Patient sample, cell culture and mouse studies suggest inhibiting ZNF395 could help treat clear cell renal cell carcinoma (ccRCC). In patients, levels of ZNF395 were higher in tumors than in normal re...
BCIQ Company Profiles
BCIQ Target Profiles